Project
Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutated melanoma: a multi-centric, national, prospective, longitudinal, non-interventional study in Switzerland – BERINGMELANOMA
Ongoing - recruitment active · 2021 until 2027
Wagner Nikolaus
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2021
End Date
2027
Financing
Industry
Phase
IV
Labels
melanoma